Simplex Trading’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,899
Closed -$1.93M 9664
2025
Q4
$2.04M Sell
1,899
-23,734
-93% -$22.7M ﹤0.01% 1968
2025
Q3
$19.6M Buy
25,633
+20,347
+385% +$15.1M 0.01% 645
2025
Q2
$4.12M Buy
+5,286
New +$4.11M ﹤0.01% 1506
2024
Q4
Sell
-5,445
Closed -$4.51M 9140
2024
Q3
$4.82M Buy
+5,445
New +$4.9M ﹤0.01% 1510
2024
Q2
Sell
-36,141
Closed -$28.9M 9356
2024
Q1
$28.1M Buy
+36,141
New +$25.7M 0.02% 532
2022
Q4
Sell
-1,748
Closed -$620K 9859
2022
Q3
$565K Buy
+1,748
New +$554K ﹤0.01% 3331
2022
Q2
Sell
-4,324
Closed -$1.3M 10580
2022
Q1
$1.24M Buy
+4,324
New +$1.11M ﹤0.01% 2642
2021
Q2
Sell
-2,857
Closed -$574K 10399
2021
Q1
$533K Buy
+2,857
New +$559K ﹤0.01% 3284
2020
Q4
Sell
-59,071
Closed -$8.82M 8747
2020
Q3
$8.74M Buy
59,071
+11,733
+25% +$1.82M 0.01% 577
2020
Q2
$7.77M Buy
+47,338
New +$7.27M 0.01% 617
2018
Q4
Sell
-218
Closed -$24.4K 7447
2018
Q3
$23K Buy
+218
New +$21.8K ﹤0.01% 5839
2018
Q2
Sell
-485
Closed -$39.8K 7652
2018
Q1
$37K Sell
485
-12,929
-96% -$1.04M ﹤0.01% 2731
2017
Q4
$1.13M Sell
13,414
-21,432
-62% -$1.82M 0.05% 350
2017
Q3
$2.98M Sell
34,846
-21,611
-38% -$1.77M 0.12% 132
2017
Q2
$4.65M Buy
+56,457
New +$4.61M 0.2% 79
2017
Q1
Sell
-131,715
Closed -$10.5M 6479
2016
Q4
$9.69M Buy
131,715
+88,040
+202% +$6.56M 0.58% 21
2016
Q3
$3.5M Buy
+43,675
New +$3.5M 0.24% 71
2016
Q1
Sell
-5,366
Closed -$406K 5930
2015
Q4
$452K Buy
5,366
+2,685
+100% +$223K 0.04% 470
2015
Q3
$224K Sell
2,681
-2,259
-46% -$191K 0.02% 842
2015
Q2
$412K Buy
+4,940
New +$376K 0.03% 460
2015
Q1
Sell
-16,921
Closed -$1.2M 5283
2014
Q4
$1.17M Buy
+16,921
New +$1.14M 0.14% 129

Other funds holding LLY

Simplex Trading's LLY Position: Q1 2026 in Review

Simplex Trading sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 1,899 shares — an estimated $1.93M sold.

Simplex Trading first reported a position in LLY in Q4 2014 and held it in 21 quarters. The position peaked at $28.1M in Q1 2024. 4,379 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Simplex Trading reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Simplex Trading sold 1,899 Eli Lilly shares in Q1 2026, an estimated $1.93M.
  • Simplex Trading first reported a position in Eli Lilly in Q4 2014 and held it in 21 quarters.
  • Simplex Trading's Eli Lilly position peaked at $28.1M in Q1 2024.
  • 4,379 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.